influence of apoe and rnf219 on behavioral and cognitive features of female patients affected by mild cognitive impairment or alzheimer’s disease

Clicks: 243
ID: 229052
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #179 of 234 articles by views in Frontiers in chemistry

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 234 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The risk for Alzheimer’s disease (AD) is associated with the presence of the 𝜀4 allele of Apolipoprotein E (APOE) gene and, recently, with a novel genetic variant of the RNF219 gene. This study aimed at evaluating interactions between APOE-𝜀4 and RNF219/G variants in the modulation of behavioral and cognitive features of two cohorts of patients suffering from mild cognitive impairment (MCI) or AD. We enrolled a total of 173 female MCI or AD patients (83 MCI; 90 AD). Subjects were screened with a comprehensive set of neuropsychological evaluations and genotyped for the APOE and RNF219 polymorphic variants. Analysis of covariance was performed to assess the main and interaction effects of APOE and RNF219 genotypes on the cognitive and behavioral scores. The analysis revealed that the simultaneous presence of APOE-𝜀4 and RNF219/G variants results in significant effects on specific neuropsychiatric scores in MCI and AD patients. In MCI patients, RNF219 and APOE variants worked together to impact the levels of anxiety negatively. Similarly, in AD patients, the RNF219 variants were found to be associated with increased anxiety levels. Our data indicate a novel synergistic activity APOE and RNF219 in the modulation of behavioral traits of female MCI and AD patients.
Reference Key
mosca2018frontiersinfluence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Alessandra Mosca;Alessandra Mosca;Alessandra Mosca;Samantha Sperduti;Samantha Sperduti;Viorela Pop;Domenico Ciavardelli;Domenico Ciavardelli;Alberto Granzotto;Alberto Granzotto;Miriam Punzi;Miriam Punzi;Liborio Stuppia;Valentina Gatta;Francesca Assogna;Nerisa Banaj;Fabrizio Piras;Federica Piras;Carlo Caltagirone;Gianfranco Spalletta;Stefano L. Sensi;Stefano L. Sensi;Stefano L. Sensi
Journal Frontiers in chemistry
Year 2018
DOI
10.3389/fnagi.2018.00092
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.